uniQure QURE
NASDAQ QURE
$38.32 -4.44 (-10.38%)
At close: Sep 24, 2026 · 4:00 PM EDT

uniQure (QURE) Share-based Compensation (2015 - 2026)

uniQure (QURE) posted Share-based Compensation of $40.8 million for Q2 2026, up 674.16% on a QoQ basis from $5.3 million in Q1 2026, and up 46924.63% year-over-year from N/an in Q2 2025.

Analysis

uniQure (QURE) Share-based Compensation (2015 - 2026) Analysis & Trends

uniQure has reported Share-based Compensation for 12 years, with the latest figure at $40.8 million in Q2 2026.

  • On a quarterly basis, Share-based Compensation rose 46924.63% year-over-year to $40.8 million in Q2 2026; TTM through Jun 2026 was $40.8 million, a 46924.63% increase from a year earlier, with the FY2025 full-year figure at $32.3 million, up 45.03% from the prior year.
  • Share-based Compensation was $40.8 million for Q2 2026 at uniQure, up from $5.3 million in the prior quarter.
  • The five-year high for Share-based Compensation was $40.8 million in Q2 2026, with the low at $86712.0 in Q2 2024.
  • Average Share-based Compensation over 5 years is $7.8 million, with a median of $7.0 million recorded in 2022.
  • The sharpest annual moves came in 2024 and 2026: Share-based Compensation slumped 99.22% in 2024, then soared 46924.63% in 2026.
  • Over 5 years, Share-based Compensation stood at $11.9 million in 2022, then sank by 40.9% to $7.0 million in 2023, then plunged by 32.55% to $4.7 million in 2024, then declined by 1.81% to $4.7 million in 2025, then jumped by 774.46% to $40.8 million in 2026.
  • The last three Share-based Compensation figures came in at $40.8 million (Q2 2026), $5.3 million (Q1 2026), and $4.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn -950.00 Mn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 166.00 Mn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn -
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 247.00 Mn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 231.00 Mn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 108.10 Mn
10 uniQure 2.96 Bn 2.96 Bn 5.49 Mn 40.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40.78 Mn
Mar 31, 2026 5.27 Mn
Dec 31, 2025 4.66 Mn
Sep 30, 2025 4.68 Mn
Jun 30, 2025 86,712.00
Mar 31, 2025 4.41 Mn
Dec 31, 2024 4.75 Mn
Sep 30, 2024 86,712.00
Jun 30, 2024 86,712.00
Mar 31, 2024 7.19 Mn
Dec 31, 2023 7.04 Mn
Sep 30, 2023 11.10 Mn
Jun 30, 2023 8.89 Mn
Mar 31, 2023 8.06 Mn
Dec 31, 2022 11.91 Mn
Sep 30, 2022 7.61 Mn
Jun 30, 2022 7.81 Mn
Mar 31, 2022 6.87 Mn
Dec 31, 2021 6.89 Mn
Sep 30, 2021 5.96 Mn
API Access

uniQure Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=QURE&period=max&api_key=YOUR_API_KEY